Matrine inhibits the proliferation and migration of lung cancer cells through regulation of the protein kinase B/glycogen synthase kinase‑3β signaling pathways

Xie,Wang; Lu,Jingjing; Lu,Qingchun; Wang,Xian; Long,Haihu; Huang,Jianhao; Guo,Zhongliang

doi:10.3892/etm.2018.6266

August-2018 Volume 16 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

August-2018 Volume 16 Issue 2

Full Size Image

Article Open Access

Matrine inhibits the proliferation and migration of lung cancer cells through regulation of the protein kinase B/glycogen synthase kinase‑3β signaling pathways

Authors:
- Wang Xie
- Jingjing Lu
- Qingchun Lu
- Xian Wang
- Haihu Long
- Jianhao Huang
- Zhongliang Guo
View Affiliations / Copyright

Affiliations: Department of Respiratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China

Copyright: © Xie et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Pages: 723-729
|
Published online on: June 7, 2018

https://doi.org/10.3892/etm.2018.6266
Expand metrics +

Abstract

Lung cancer is the leading cause of cancer‑related mortality worldwide. Despite recent advances in treatment, lung cancer remains an incurable disease. Matrine, an active compound isolated from Sophora flavescens, has been demonstrated to inhibit proliferation and induce apoptosis of tumor cells. However, the protective effects and molecular mechanisms of matrine in lung cancer remain elusive. In the present study, the lung cancer cells H1299 and A549 were used to investigate how matrine affects the proliferation, migration and apoptosis of lung cancer cells in vitro. It was demonstrated that matrine is able to significantly suppress the proliferation and colony formation of lung cancer cells in vitro. Using cell apoptosis analysis, wound‑healing and Transwell assays, it was demonstrated that matrine induced cellular apoptosis and inhibited the migration of lung cancer cells. Further experiments revealed that matrine significantly suppressed the phosphorylation of protein kinase B (Akt) and glycogen synthase kinase‑3β (GSK‑3β). The present results suggested that matrine inhibits lung cancer cell proliferation, and induces cell apoptosis by suppressing the Akt/GSK‑3β signaling pathway, which demonstrated that matrine may have therapeutic potential for lung cancer.

View Figures

View References

1	Hong X, Chen Q, Ding L, Liang Y, Zhou N, Fang W, Chen X and Wu H: Clinical benefit of continuing crizotinib therapy after initial disease progression in Chinese patients with advanced ALK-rearranged non-small-cell lung cancer. Oncotarget. 8:41631–41640. 2017. View Article : Google Scholar : PubMed/NCBI
2	Pearce A, Bradley C, Hanly P, O'Neill C, Thomas AA, Molcho M and Sharp L: Projecting productivity losses for cancer-related mortality 2011–2030. Bmc Cancer. 16:8042016. View Article : Google Scholar : PubMed/NCBI
3	Midha A, Dearden S and McCormack R: EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: A systematic review and global map by ethnicity (mutMapII). Am J Cancer Res. 5:2892–2911. 2015.PubMed/NCBI
4	Huang H, Du T, Xu G, Lai Y, Fan X, Chen X, Li W, Yue F, Li Q, Liu L and Li K: Matrine suppresses invasion of castration-resistant prostate cancer cells by downregulating MMP-2/9 via NF-κB signaling pathway. Int J Oncol. 50:640–648. 2017. View Article : Google Scholar : PubMed/NCBI
5	Liu Z, Zhang Y, Tang Z, Xu J, Ma M, Pan S, Qiu C, Guan G and Wang J: Matrine attenuates cardiac fibrosis by affecting ATF6 signaling pathway in diabetic cardiomyopathy. Eur J Pharmacol. 804:21–30. 2017. View Article : Google Scholar : PubMed/NCBI
6	Huang WC, Chan CC, Wu SJ, Chen LC, Shen JJ, Kuo ML, Chen MC and Liou CJ: Matrine attenuates allergic airway inflammation and eosinophil infiltration by suppressing eotaxin and Th2 cytokine production in asthmatic mice. J Ethnopharmacol. 151:470–477. 2014. View Article : Google Scholar : PubMed/NCBI
7	Yong J, Wu X and Lu C: Anticancer advances of matrine and its derivatives. Curr Pharm Des. 21:3673–3680. 2015. View Article : Google Scholar : PubMed/NCBI
8	Qian L, Liu Y, Xu Y, Ji W, Wu Q, Liu Y, Gao Q and Su C: Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways. Cancer Lett. 368:126–134. 2015. View Article : Google Scholar : PubMed/NCBI
9	Ma Y, Zou F, Xiong J, Wan W, Yin L, Li X, Bei Z, Yuan L, Meng S, Wang J and Song G: Effect of Matrine on HPAC cell migration by down-regulating the expression of MT1-MMP via Wnt signaling. Cancer Cell Int. 15:592015. View Article : Google Scholar : PubMed/NCBI
10	Xie M, Yi X, Wang R, Wang L, He G, Zhu M, Qi C, Liu Y, Ye Y, Tan S and Tang A: 14-Thienyl methylene matrine (YYJ18), the derivative from matrine, induces apoptosis of human nasopharyngeal carcinoma cells by targeting MAPK and PI3K/Akt pathways in vitro. Cell Physiol Biochem. 33:1475–1483. 2014. View Article : Google Scholar : PubMed/NCBI
11	Wei L, Yao Y, Zhao K, Huang Y, Zhou Y, Zhao L, Guo Q and Lu N: Oroxylin A inhibits invasion and migration through suppressing ERK/GSK-3β signaling in snail-expressing non-small-cell lung cancer cells. Mol Carcinog. 55:2121–2134. 2016. View Article : Google Scholar : PubMed/NCBI
12	Ho MY, Liang SM, Hung SW and Liang CM: MIG-7 controls COX-2/PGE2-mediated lung cancer metastasis. Cancer Res. 73:439–449. 2013. View Article : Google Scholar : PubMed/NCBI
13	Chen J, Mei Q, Xu YC, Du J, Wei Y and Xu ZM: Effects of Matrine Injection on T-lymphocyte subsets of patients with malignant tumor after gamma knife radiosurgery. Zhong Xi Yi Jie He Xue Bao. 4:78–79. 2006.(In Chinese). View Article : Google Scholar : PubMed/NCBI
14	Yin H, Que R, Liu C, Ji W, Sun B, Lin X, Zhang Q, Zhao X, Peng Z, Zhang X, et al: Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma. Cancer Lett. 425:54–64. 2018. View Article : Google Scholar : PubMed/NCBI
15	Wu L, Wang G, Liu S, Wei J, Zhang S, Li M, Zhou G and Wang L: Synthesis and biological evaluation of matrine derivatives containing benzo-α-pyrone structure as potent anti-lung cancer agents. Sci Rep. 6:359182016. View Article : Google Scholar : PubMed/NCBI
16	Zhou N, Li J, Li T, Chen G, Zhang Z and Si Z: Matrine-induced apoptosis in Hep3B cells via the inhibition of MDM2. Mol Med Rep. 15:442–450. 2017. View Article : Google Scholar : PubMed/NCBI
17	Wu L, Wang G, Wei J, Huang N, Zhang S, Yang F, Li M, Zhou G and Wang L: Matrine derivative YF-18 inhibits lung cancer cell proliferation and migration through down-regulating Skp2. Oncotarget. 8:11729–11738. 2017.PubMed/NCBI
18	Ali M, Wu Y, Ghosh D, Do BH, Chen K, Dawson MR, Fang N, Sulchek TA and El-Sayed MA: Nuclear membrane-targeted gold nanoparticles inhibit cancer cell migration and invasion. ACS Nano. 11:3716–3726. 2017. View Article : Google Scholar : PubMed/NCBI
19	Labernadie A, Kato T, Brugués A, Serra-Picamal X, Derzsi S, Arwert E, Weston A, González-Tarragó V, Elosegui-Artola A, Albertazzi L, et al: A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat Cell Biol. 19:224–237. 2017. View Article : Google Scholar : PubMed/NCBI
20	Jacquemet G, Baghirov H, Georgiadou M, Sihto H, Peuhu E, Cettour-Janet P, He T, Perälä M, Kronqvist P, Joensuu H and Ivaska J: L-type calcium channels regulate filopodia stability and cancer cell invasion downstream of integrin signalling. Nat Commun. 7:132972016. View Article : Google Scholar : PubMed/NCBI
21	Wu X, Zhou J, Cai D and Li M: Matrine inhibits the metastatic properties of human cervical cancer cells via downregulating the p38 signaling pathway. Oncol Rep. 38:1312–1320. 2017. View Article : Google Scholar : PubMed/NCBI
22	Yang SF, Yang WE, Kuo WH, Chang HR, Chu SC and Hsieh YS: Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases. Arch Oral Biol. 53:287–294. 2008. View Article : Google Scholar : PubMed/NCBI
23	Zhou LE, Wang WJ, Bai JY and Cheng GF: Effects of ginkgolide B on arachidonic acid metabolizing enzymes and level of intracellular calcium in rat polymorphonuclear leukocytes. Yao Xue Xue Bao. 36:92–95. 2001.(In Chinese). PubMed/NCBI
24	Li H, Tan G, Jiang X, Qiao H, Pan S, Jiang H, Kanwar JR and Sun X: Therapeutic effects of matrine on primary and metastatic breast cancer. Am J Chin Med. 38:1115–1130. 2010. View Article : Google Scholar : PubMed/NCBI
25	Davis NM, Sokolosky M, Stadelman K, Abrams SL, Libra M, Candido S, Nicoletti F, Polesel J, Maestro R, D'Assoro A, et al: Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: Possibilities for therapeutic intervention. Oncotarget. 5:4603–4650. 2014. View Article : Google Scholar : PubMed/NCBI
26	Sagredo AI, Sagredo EA, Cappelli C, Báez P, Rodrigo AM, Blanco C, Tapia JC, Echeverria C, Cerda O, Stutzin A, et al: TRPM4 regulates Akt/GSK3-β activity and enhances β-catenin signaling and cell proliferation in prostate cancer cells. Mol Oncol. 12:151–165. 2018. View Article : Google Scholar : PubMed/NCBI
27	Zhang PP, Wang PQ, Qiao CP, Zhang Q, Zhang JP, Chen F, Zhang X, Xie WF, Yuan ZL, Li ZS and Chen YX: Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3β/β-catenin axis and TGF-β induced EMT with sophocarpine. Cancer Lett. 376:95–103. 2016. View Article : Google Scholar : PubMed/NCBI
28	Wu J, Hu G, Dong Y, Ma R, Yu Z, Jiang S, Han Y, Yu K and Zhang S: Matrine induces Akt/mTOR signalling inhibition-mediated autophagy and apoptosis in acute myeloid leukaemia cells. J Cell Mol Med. 21:1171–1181. 2017. View Article : Google Scholar : PubMed/NCBI
29	Niu H, Zhang Y, Wu B, Zhang Y, Jiang H and He P: Matrine induces the apoptosis of lung cancer cells through downregulation of inhibitor of apoptosis proteins and the Akt signaling pathway. Oncol Rep. 32:1087–1093. 2014. View Article : Google Scholar : PubMed/NCBI
30	Hseu YC, Thiyagarajan V, Tsou HT, Lin KY, Chen HJ, Lin CM, Liao JW and Yang HL: In vitro and in vivo anti-tumor activity of CoQ0 against melanoma cells: inhibition of metastasis and induction of cell-cycle arrest and apoptosis through modulation of Wnt/β-catenin signaling pathways. Oncotarget. 7:22409–22426. 2016. View Article : Google Scholar : PubMed/NCBI
31	Xu G, Yu H, Shi X, Sun L, Zhou Q, Zheng D, Shi H, Li N, Zhang X and Shao G: Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2. BMC Pulm Med. 14:1742014. View Article : Google Scholar : PubMed/NCBI
32	Chen L, Li YC, Wu L, Yu GT, Zhang WF, Huang CF and Sun ZJ: TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma. J Cell Mol Med. 22:1337–1349. 2018.PubMed/NCBI
33	Liu L, Zhou XM, Yang FF, Miao Y, Yin Y, Hu XJ, Hou G, Wang QY and Kang J: TRIM22 confers poor prognosis and promotes epithelial-mesenchymal transition through regulation of AKT/GSK3β/β-catenin signaling in non-small cell lung cancer. Oncotarget. 8:62069–62080. 2017.PubMed/NCBI